Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study.

Almagro P, Martínez-Camblor P, Miravitlles M, Rodríguez-Carballeira M, Navarro A, Lamprecht B, Ramirez-Garcia Luna AS, Kaiser B, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Anto JM, Turner AM, Han MK, Langhammer A, Sternberg A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosío B, Ancochea J, Echazarreta A, Roche N, Burgel PR, Sin DD, Puhan MA, Soriano JB; 3CIA collaboration.

COPD. 2019 Mar 14:1-10. doi: 10.1080/15412555.2018.1484440. [Epub ahead of print]

PMID:
30870059
2.

Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.

Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, Diez-Manglano J, Murio C, Heredia JL; Working Group on COPD, SpanishSociety of Internal Medicine*.

Chest. 2014 May;145(5):972-980. doi: 10.1378/chest.13-1328.

PMID:
24077342
3.

Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index.

Navarro A, Costa R, Rodriguez-Carballeira M, Yun S, Lapuente A, Barrera A, Acosta E, Viñas C, Heredia JL, Almagro P.

Rev Clin Esp. 2015 Nov;215(8):431-8. doi: 10.1016/j.rce.2015.06.004. Epub 2015 Jul 13. English, Spanish.

PMID:
26183602
4.

External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.

Morales DR, Flynn R, Zhang J, Trucco E, Quint JK, Zutis K.

Respir Med. 2018 May;138:150-155. doi: 10.1016/j.rmed.2018.04.003. Epub 2018 Apr 12.

PMID:
29724388
5.

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.

Soriano JB, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Puhan MA, Sobradillo P, Lange P, Sternberg AL, Garcia-Aymerich J, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Roche N, Sin DD.

Lancet Respir Med. 2015 Jun;3(6):443-50. doi: 10.1016/S2213-2600(15)00157-5. Epub 2015 May 17.

PMID:
25995071
6.

Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.

Grolimund E, Kutz A, Marlowe RJ, Vögeli A, Alan M, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

COPD. 2015 Jun;12(3):295-305. doi: 10.3109/15412555.2014.949002. Epub 2014 Sep 17.

PMID:
25230352
7.

Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.

Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, Soriano JB; Working Group on, COPD, Spanish Society of Internal Medicine.

Chest. 2012 Nov;142(5):1126-1133. doi: 10.1378/chest.11-2413.

PMID:
23303399
8.

Determining prognosis in acute exacerbation of COPD.

Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:467-475. doi: 10.2147/COPD.S122382. eCollection 2017.

9.

Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.

Duenk RG, Verhagen C, Bronkhorst EM, Djamin RS, Bosman GJ, Lammers E, Dekhuijzen P, Vissers K, Engels Y, Heijdra Y.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 20;12:2121-2128. doi: 10.2147/COPD.S140037. eCollection 2017.

10.

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD.

Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, Gibson GJ, Bourke SC.

Thorax. 2017 Aug;72(8):686-693. doi: 10.1136/thoraxjnl-2016-209298. Epub 2017 Feb 24.

11.

Prognostic assessment in COPD without lung function: the B-AE-D indices.

Boeck L, Soriano JB, Brusse-Keizer M, Blasi F, Kostikas K, Boersma W, Milenkovic B, Louis R, Lacoma A, Djamin R, Aerts J, Torres A, Rohde G, Welte T, Martinez-Camblor P, Rakic J, Scherr A, Koller M, van der Palen J, Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Tamm M, Stolz D.

Eur Respir J. 2016 Jun;47(6):1635-44. doi: 10.1183/13993003.01485-2015. Epub 2016 Apr 21.

12.

Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study.

Almagro P, Martinez-Camblor P, Soriano JB, Marin JM, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Miravitlles M.

PLoS One. 2014 Feb 27;9(2):e89866. doi: 10.1371/journal.pone.0089866. eCollection 2014.

13.

An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.

Ozgür ES, Nayci SA, Özge C, Taşdelen B.

Respir Care. 2012 Sep;57(9):1452-9. doi: 10.4187/respcare.01440. Epub 2012 Feb 17.

14.

Severity of acidosis affects long-term survival in COPD patients with hypoxemia after intensive care unit discharge.

Gungor S, Kargin F, Irmak I, Ciyiltepe F, Acartürk Tunçay E, Atagun Guney P, Aksoy E, Ocakli B, Adiguzel N, Karakurt Z.

Int J Chron Obstruct Pulmon Dis. 2018 May 9;13:1495-1506. doi: 10.2147/COPD.S159504. eCollection 2018.

15.

Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts.

Puhan MA, Hansel NN, Sobradillo P, Enright P, Lange P, Hickson D, Menezes AM, ter Riet G, Held U, Domingo-Salvany A, Mosenifar Z, Antó JM, Moons KG, Kessels A, Garcia-Aymerich J; International COPD Cohorts Collaboration Working Group.

BMJ Open. 2012 Dec 12;2(6). pii: e002152. doi: 10.1136/bmjopen-2012-002152. Print 2012.

16.

In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.

Ho TW, Tsai YJ, Ruan SY, Huang CT, Lai F, Yu CJ; HINT Study Group.

PLoS One. 2014 Dec 9;9(12):e114866. doi: 10.1371/journal.pone.0114866. eCollection 2014.

17.

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.

Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Pechoux CL, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Mariani L, Wunder JS, Pollock RE, Casali PG, Gronchi A.

Lancet Oncol. 2016 May;17(5):671-80. doi: 10.1016/S1470-2045(16)00010-3. Epub 2016 Apr 5.

PMID:
27068860
18.

Risk assessment of readmissions following an initial COPD-related hospitalization.

Baker CL, Zou KH, Su J.

Int J Chron Obstruct Pulmon Dis. 2013;8:551-9. doi: 10.2147/COPD.S51507. Epub 2013 Nov 12.

19.

Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.

Ho SC, Wang JY, Kuo HP, Huang CD, Lee KY, Chuang HC, Feng PH, Chen TT, Hsu MF.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 31;11:2075-80. doi: 10.2147/COPD.S107326. eCollection 2016.

20.

Validation of PROFUND prognostic index over a four-year follow-up period.

Bernabeu-Wittel M, Moreno-Gaviño L, Ollero-Baturone M, Barón-Franco B, Díez-Manglano J, Rivas-Cobas C, Murcia-Zaragoza J, Ramos-Cantos C, Fernández-Moyano A; PROFUND researchers.

Eur J Intern Med. 2016 Dec;36:20-24. doi: 10.1016/j.ejim.2016.07.022. Epub 2016 Aug 1.

PMID:
27491587

Supplemental Content

Support Center